Women prescribed penicillins, erythromycins, and cephalosporins for bacterial infections during their first trimester may be reassured that these ntibacterial agents are not significantly associated with birth defects, new research shows.
Women prescribed penicillins, erythromycins, and cephalosporins for bacterial infections during their first trimester may be reassured that these antibacterial agents are not significantly associated with birth defects, according to researchers at the Centers for Disease Control and Prevention and the University of Arkansas for Medical Sciences in Little Rock.
For women prescribed sulfonamides and nitrofurantoins during pregnancy, the news is less rosy.
The population-based, multisite, case-controlled study compared 13,155 women whose pregnancies were affected by 1 of more than 30 types of birth defects with 4,941 matched controls. Reported use of antibiotics increased during the first trimester. Of these, sulfonamides were associated with anencephaly, hypoplastic left heart syndrome, coarctation of the aorta, choanal atresia, transverse limb deficiency, and diaphragmatic hernia. Nitrofurantonins were associated with anophthalmia or microphthalmos, septal defects, and cleft lip or palate. However, infants of women treated with erythromycins, penicillins, cephalosporins, and quinolones had minimal risk of birth defects.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More